Log In
Print this Print this

Leustatin, cladribine

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionSynthetic antineoplastic agent for continuous intravenous infusion
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today